voice search
Erlocip 150mg Erlotinib Hydrochloride Tablets - 150 Mg Strength, Pack Of 30 Tablets | Prescription Drug For Medical Guidance

Erlocip 150mg Erlotinib Hydrochloride Tablets - 150 Mg Strength, Pack Of 30 Tablets | Prescription Drug For Medical Guidance

Price:

Get Latest Price

Brand Name :

Erlocip

In Stock

In Stock

Product Specifications

IndicationPatients with metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer
Pacakaging (Quantity Per Box)30 tablets per box
Origin of MedicineAllopathic
Salt CompositionErlotinib Hydrochloride
Dosage FormOral tablets
Drug TypeOther, Prescription only
IngredientsErlotinib Hydrochloride
Physical FormTablets
FunctionOther, Anti-cancer (EGFR inhibitor)
Recommended ForNon-Small Cell Lung Cancer, Pancreatic Cancer
Dosage150 mg once daily or as prescribed by physician
Dosage GuidelinesAs directed by physician; swallow whole with water, do not crush or chew
Suitable ForAdults
Quantity30 tablets
Storage InstructionsStore below 30AdegC, protect from light and moisture
Packaging DetailsPACK OF 30 TABLETS

Product Overview

Key Features

ERLOCIP ERLOTINIB HYDROCHLORIDE

Company Details

RADHAKISHAN PHARMACEUTICALS, Established in 2011 at Delhi in Delhi, is a leading Exporter,Distributor,Supplier,Trading Company,Wholesaler of Common Medicines & Drugs in India. RADHAKISHAN PHARMACEUTICALS is one of Trade India's verified and trusted sellers of listed products. With extensive experience in supplying and trading ERLOCIP 150MG ERLOTINIB HYDROCHLORIDE TABLETS, RADHAKISHAN PHARMACEUTICALS has made a reputed name for itself in the market with high-quality ABAMUNE ABACAVIR TABLETS, ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS, ABIRAPRON ABIRATERONE ACETATE TABLETS, etc.
Focusing on a customer-centric approach, RADHAKISHAN PHARMACEUTICALS has a pan-India presence and caters to a huge consumer base throughout the country. Buy Common Medicines & Drugs in bulk from RADHAKISHAN PHARMACEUTICALS at Trade India quality-assured products.

Business Type

Exporter, Distributor, Supplier, Trading Company, Wholesaler

Employee Count

40

Establishment

2011

Working Days

Monday To Saturday

GST NO

07AFIPJ3910R1Z2

Certification

ISO 9001:2015 CERTIFIED

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

GST

GST - 07AFIPJ3910R1Z2

Delhi, Delhi

Proprietor

Mr. Deepak Jindal

Members since

16 Years

Address

Shop No.1, Second Floor, Property No. 4634/1, Plot No-19, Ward No.11, Ansari Road, Daryaganj, Delhi, Delhi, 110002, India

erlotinib tablets in Delhi

Report incorrect details

Compare With Similar Products

Buyer Feedback

3

Indication

Patients with metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer

Used in the treatment of pancreatic cancer and non-small cell lung cancer.

Pacakaging (Quantity Per Box)

30 tablets per box

30 tablets

Origin Of Medicine

Allopathic

India

Salt Composition

Erlotinib Hydrochloride

Erlotinib

Dosage Form

Oral tablets

Tablet

Drug Type

Other, Prescription only

Specific Drug

General Medicines

Ingredients

Erlotinib Hydrochloride

ERLOTINIB 150

Erlotinib

Physical Form

Tablets

Tablets

Tablets

Function

Other, Anti-cancer (EGFR inhibitor)

Cancer Treatment

Anti-Cancer

Recommended For

Non-Small Cell Lung Cancer, Pancreatic Cancer

LUNG CANCER,PANCREATIC CANCER

Used in the treatment of pancreatic cancer and non-small cell lung cancer.

Dosage

150 mg once daily or as prescribed by physician

The recommended daily dose of TARCEVA for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs. Recommended Dose - Pancreatic Cancer The recommended daily dose of TARCEVA for pancreatic cancer is 100 mg taken once daily in combination with gemcitabine. Take TARCEVA on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food. Treatment should continue until disease progression or unacceptable toxicity occurs [see Clinical Studies]. Dose Modifications Adverse Reactions PulmonaryaEUR Interstitial Lung Disease (ILD) Discontinue TARCEVA During diagnostic evaluation for possible ILD Withhold TARCEVA* HepaticaEUR Severe hepatic toxicity that does not improve significantly or resolve within three weeks Discontinue TARCEVA In patients with pre-existing hepatic impairment or biliary obstruction for doubling of bilirubin or tripling of transaminases values over baseline Withhold TARCEVA* and consider discontinuation In patients without pre-existing hepatic impairment for total bilirubin levels greater than 3 times the upper limit of normal or transaminases greater than 5 times the upper limit of normal Withhold ERLONAT and consider

As directed by Physician

Dosage Guidelines

As directed by physician; swallow whole with water, do not crush or chew

As Directed By The Physician

Suitable For

Adults

Teenagers, Adults, Aged Person

Quantity

30 tablets

30 tablets Unit

Storage Instructions

Store below 30AdegC, protect from light and moisture

ROOM TEMP. 10 -30 C

Cool And Dry Place

Packaging Details

PACK OF 30 TABLETS

1*30S

30 tablets in a bottle

Price Or Price Range

122.96-136.63 USD ($) (Approx.)

2850.0 INR (Approx.)

Minimum Order Quantity

2 Bottle/Bottles

500 Bottle/Bottles

Payment Terms

Cash in Advance (CID)

Paypal, Cash Advance (CA), Cash in Advance (CID), Western Union, Others, Letter of Credit (L/C), Cheque, Telegraphic Transfer (T/T)

Supply Ability

20 Per Week

10000 Per Month

Delivery Time

2 Week

7 Days

Main Export Market(s)

Australia, South America, Middle East, Africa, Western Europe, Asia, Central America, Eastern Europe, North America

Eastern Europe, Western Europe, Middle East, Asia, Australia, Central America, North America, South America

Main Domestic Market

All India

All India